News | July 21, 2008

Toshiba’s Flat Panel System Guides Live Heart Procedures

July 21, 2008 – Toshiba America Medical Systems said today that four live cases using the Infinix CF-i/BP will be showcased at the Pediatric and Adult Interventional Cardiac Symposium (PICS-AICS) held in Las Vegas July 20-23.

Two hospitals that recently acquired the Infinix CF-i/BP will be performing live cases over the course of the symposium – Rush University Medical Center and the Children’s Healthcare of Atlanta Sibley Heart Center.

On July 21, Ziyad M. Hijazi, M.D., director of the Rush Center for Congenital and Structural Heart Disease, performed a closure of an atrial septal defect and patent ductus arteriosus closure. Dr. Hijazi is the course director and a founding member of PICS-AICS.

On July 22, Robert N. Vincent, M.D., co-medical director of the Heart Transplant Program and Director of the Cardiac Catheterization Lab at Children’s Sibley Heart Center will perform two live procedures. The first will be a pulmonary artery angioplasty and the second will be an atrial septal defect closure.

The design of the Infinix CF-i/BP system will assist with the hybrid approach, enhancing collaboration between clinicians and critical equipment to aid diagnosis and treatment.

“We have been using two Toshiba labs for just about a year now. They have been dependable and provide excellent image quality,” said Dr. Vincent. “The thing I like best about them is the five axis system that allows us to move both AP and lateral detectors away from the head of the table giving better access for anesthesia, echo and procedures being performed from the neck or upper chest area.”

The Pediatric and Adult Interventional Cardiac Symposium (PICS-AICS) covers the burgeoning field of interventional therapies for pediatric and adult patients with congenital and structural heart disease. The symposium, held in Las Vegas, Nev., features distinguished faculty lectures, interactive discussions, workshops, live case demonstrations from 12 cardiac centers from around the world, and breakout sessions, covering topics such as devices, implantable valves, bioabsorbable technology, stents, balloons and many new aspects of interventional cardiology.

For more information:,

Related Content

SherpaPak Cardiac Transport System Cleared for Pediatric and Small Donor Hearts
Technology | Cardiovascular Surgery | February 01, 2019
Paragonix Technologies Inc. recently received clearance from the U.S. Food and Drug Administration (FDA) for a design...
Transplanting Pig Hearts Into Humans One Step Closer. A pig heart, shown here, is very similar in size and anatomy to a human heart. For this reason, pigs are used extensively in pre-clinical animal testing for new implantable cardiovascular devices. If pig hearts could be used for human transplantation, it would greatly alleviate shortages of donor human hearts.

A pig heart, shown here, is very similar in size and anatomy to a human heart. For this reason, pigs are used extensively in pre-clinical animal testing for new implantable cardiovascular devices. If pig hearts could be used for human transplantation, it would greatly alleviate shortages of donor human hearts.

News | Cardiovascular Surgery | December 11, 2018
The scientific journal Nature recently published an article from Munich University Hospital which describes the long-...
Bilateral Artery Use Does Not Improve 10-Year CABG Outcomes
News | Cardiovascular Surgery | September 06, 2018
While it is firmly established that the use of one internal thoracic artery can improve life expectancy in coronary...
Mandatory Public Coronary Artery Bypass Grafting Reporting Associated With Better Patient Outcomes
News | Cardiovascular Surgery | April 30, 2018
Mandatory public reporting of coronary artery bypass grafting (CABG) results in Massachusetts was associated with...
Gecko Biomedical Receives CE Mark Approval for Setalum Sealant
News | Cardiovascular Surgery | September 19, 2017
Gecko Biomedical announced it has received CE Mark approval for its Setalum Sealant, allowing the company to market its...
ClearFlow Inc. Announces Positive U.S. Clinical Trial Results
News | Cardiovascular Surgery | September 08, 2017
September 8, 2017 — ClearFlow Inc.
Videos | Cardiovascular Surgery | July 19, 2017
This video educational session, provided in partnership with the American Society of Echocardiography (ASE), is title
Intensive Glycemic Control Program Produces Significant Per-Patient Cost Savings for CABG Surgery
News | Cardiovascular Surgery | May 25, 2017
A new study from Emory University observed a near-20 percent reduction in perioperative complications, a 1.2-day...
Risk of Heart Transplant Rejection Reduced by Desensitizing Patient Antibodies
News | Cardiovascular Surgery | May 23, 2017
The risk of heart transplant rejection can be reduced by desensitizing patient antibodies, according to research...
Overlay Init